UVFT Projected Dividend Yield
UV Flu Technologies Inc. ( OTCBB : UVFT )UV Flu Technologies focuses on the research, development, manufacturing, and sales of air purification systems and products. Co. sells ViraTech UV-400 as a Class II medical device. Co.'s RxAir product lines are: RX-3000, which is a hospital-grade HEPA air filter; CR-3000, which is a construction grade version of the RX-3000; RX-4000, which is a prototype, metal cabinet wall-mounted commercial version of the RX-3000; RX-4500, which is a larger commercial version of the RX-3000; RX-6500, which is a bio-terrorism version of the above unit; and RX Air Plus, which is a system combining two U.S. Food and Drug Administration cleared medical devices, the RX-3000, and two Viratech UV-400's. 21 YEAR PERFORMANCE RESULTS |
UVFT Dividend History Detail UVFT Dividend News UVFT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |